TABLE.
1 | Start ART in all HIV-infected individuals with active TB, irrespective of the CD4 cell count (strong recommendation, low quality of evidence) |
2 | Start anti-tuberculosis treatment first, followed by ART as soon as possible afterwards (and within the first 8 weeks; strong recommendation, moderate quality of evidence) |
3 | Use efavirenz as the preferred NNRTI in patients starting ART while on anti-tuberculosis treatment (strong recommendation, high quality of evidence) |
WHO = World Health Organization; HIV = human immunodeficiency virus; TB = tuberculosis; ART = antiretroviral therapy; NNRTI = non-nucleoside reverse transcriptase inhibitor.